€7.5 Million Granted to Collaborative PROTO Project led by Charité to Study Pluri’s PLX-PAD Cells for Osteoarthritis Treatment

Pluri, Inc. announced that a €7.5 million non-dilutive grant from the European Union’s Horizon Europe program has been awarded to Advanced PeRsOnalized Therapies for Osteoarthritis (PROTO), an international collaboration led by Charité, Berlin Institute of Health Center for Regenerative Therapies.